Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
medical-devices: Archive
Globus Medical (GMED) Hits 52-Week High: What's Driving It?
by Zacks Equity Research
Globus Medical (GMED) outperforms the industry due to its stellar quarterly performance and impactful launches.
RMDNegative Net Change GMEDNegative Net Change MEDPPositive Net Change HIMSPositive Net Change
medical medical-devices
Buy 5 Medical Instruments Stocks to Enhance Your Portfolio
by Nalak Das
We have narrowed our search to five Medical Instruments stocks with strong potential for 2024. These stocks are: ALC, RXST, HOLX, VCYT, MASI.
HOLXNegative Net Change ALCNegative Net Change MASIPositive Net Change VCYTPositive Net Change RXSTNegative Net Change
medical-devices
Intuitive Surgical (ISRG) Hits 52-Week High on Procedure Demand
by Zacks Equity Research
Intuitive Surgical's (ISRG) da Vinci procedure volume, coupled with strong Ion procedure growth, is fueling the rally in the company???s share price.
ISRGNegative Net Change DVAPositive Net Change ALGNNegative Net Change MEDPPositive Net Change
medical medical-devices
Here's Why You Should Retain Inari Medical (NARI) for Now
by Zacks Equity Research
Inari Medical (NARI) continues to gain from its expanded product portfolio. However, continued loss at the operating level raises concern.
BSXNegative Net Change ECLNegative Net Change DVAPositive Net Change NARIPositive Net Change
medical medical-devices
CVS Health (CVS) Expands Food and Beverage Line With New Launch
by Zacks Equity Research
CVS Health's (CVS) Well Market brand offers a blend of mouthwatering flavors and nutritious options, expertly crafted and taste-tested by food enthusiasts.
RMDNegative Net Change CVSNegative Net Change MEDPPositive Net Change EHCNegative Net Change
medical medical-devices
Three Reasons to Retain Merit Medical (MMSI) Stock for Now
by Zacks Equity Research
Merit Medical's (MMSI) strong product portfolio raises optimism about the stock.
BSXNegative Net Change ECLNegative Net Change DVAPositive Net Change MMSINegative Net Change
medical medical-devices
Merit Medical's (MMSI) Latest Launch to Boost Patient Care
by Zacks Equity Research
Merit Medical's (MMSI) latest offering is likely to create an efficient approach to inflation, thereby providing improved patient care.
BSXNegative Net Change ECLNegative Net Change DVAPositive Net Change MMSINegative Net Change
medical medical-devices
AngioDynamics' (ANGO) AlphaVac System Gets CE Mark Approval
by Zacks Equity Research
AngioDynamics (ANGO) announces the European CE Mark approval of its AlphaVac F1885 System, which is likely to expand the range of therapy alternatives available to pulmonary embolism patients.
BSXNegative Net Change ECLNegative Net Change ANGOPositive Net Change ALGNNegative Net Change
medical medical-devices
Reasons to Add HealthEquity (HQY) Stock to Your Portfolio
by Zacks Equity Research
HealthEquity's (HQY) sustained strength in HSAs raises optimism about the stock.
BSXNegative Net Change ECLNegative Net Change DVAPositive Net Change HQYNegative Net Change
medical medical-devices
First Interstate BancSystem (FIBK)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
FIBKNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Here's Why You Should Buy Haemonetics (HAE) Stock Now
by Zacks Equity Research
Strong prospects of the Plasma franchise and favorable solvency bode well for Haemonetics (HAE).
RMDNegative Net Change HAEPositive Net Change MEDPPositive Net Change HIMSPositive Net Change
medical medical-devices
Medtronic's (MDT) MiniMed 780G AID System Wins New Accolade
by Zacks Equity Research
Medtronic's (MDT) MiniMed 780G system gets recognized among Fast Company's 2024 World Changing Ideas.
MDTNegative Net Change RMDNegative Net Change MEDPPositive Net Change HIMSPositive Net Change
medical medical-devices
DaVita (DVA) Gains 34.5% YTD: What's Driving the Stock?
by Zacks Equity Research
DaVita's (DVA) shares gain on the back of strong fundamentals. However, dependence on commercial payers can be a cause of concern.
BSXNegative Net Change ECLNegative Net Change DVAPositive Net Change ALGNNegative Net Change
medical medical-devices
Three Reasons to Retain Inspire Medical (INSP) Stock for Now
by Zacks Equity Research
Inspire Medical's (INSP) focus on R&D raises optimism about the stock.
BSXNegative Net Change ECLNegative Net Change DVAPositive Net Change INSPNegative Net Change
medical medical-devices
McKesson (MCK) Hits 52-Week High: What's Driving the Stock?
by Zacks Equity Research
Investors are optimistic about McKesson's (MCK) strength in its Biologics business.
DVAPositive Net Change ALGNNegative Net Change MCKNegative Net Change MEDPPositive Net Change
medical medical-devices
Veracyte (VCYT) Up 6% Since Last Earnings: Will it Continue?
by Zacks Equity Research
Investors are optimistic about Veracyte (VCYT) led by strength in the testing business and upbeat guidance.
RMDNegative Net Change VCYTPositive Net Change MEDPPositive Net Change EHCNegative Net Change
medical medical-devices
Should You Buy Sierra Bancorp (BSRR) After Golden Cross?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
BSRRNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Here's Why You Should Hold on to Abbott (ABT) Stock for Now
by Zacks Equity Research
Abbott's (ABT) share recovery in the Nutrition business buoys optimism.
ABTNegative Net Change MEDPPositive Net Change HIMSPositive Net Change HITIPositive Net Change
medical medical-devices
Philips' (PHG) Reports Positive AI-Powered Cardiac Study Data
by Zacks Equity Research
Philips' (PHG) AI-powered cardiac monitoring solutions demonstrate significantly lower re-admissions and a higher rate of survival in the retrospective study evaluating it in stroke patients.
BSXNegative Net Change ECLNegative Net Change PHGPositive Net Change ALGNNegative Net Change
medical medical-devices
Masimo's (MASI) New Offering to Serve Personalized Audio Market
by Zacks Equity Research
Masimo's (MASI) new product offering is expected to enable it to expand its footprint in the personalized hearables market by offering personalized listening experiences.
ECLNegative Net Change DVAPositive Net Change MASIPositive Net Change VEEVNegative Net Change
medical medical-devices
Boston Scientific (BSX) Reaches 52-Week High: What's Aiding It?
by Zacks Equity Research
Investors are optimistic about Boston Scientific's (BSX) impressive market share gain in the MedSurg segment and continued geographical expansion.
BSXNegative Net Change ECLNegative Net Change DVAPositive Net Change VEEVNegative Net Change
medical medical-devices
Here's Why You Should Hold Surmodics (SRDX) Stock for Now
by Zacks Equity Research
Surmodics' (SRDX) solid prospects in the thrombectomy business raise optimism about the stock.
DVAPositive Net Change ALGNNegative Net Change SRDXPositive Net Change MEDPPositive Net Change
medical medical-devices
Here's Why Investors Should Buy ResMed (RMD) Stock Now
by Zacks Equity Research
Investors are optimistic about ResMed's (RMD) potential in digital health and expansion in the international market.
RMDNegative Net Change MEDPPositive Net Change HIMSPositive Net Change HITIPositive Net Change
medical medical-devices
Boston Scientific (BSX) mCRM System Study Outcome Favorable
by Zacks Equity Research
Boston Scientific (BSX) mCRM System is designed to communicate wirelessly and coordinate painless intracardiac anti-tachycardia pacing (ATP) therapy.
BSXNegative Net Change RMDNegative Net Change MEDPPositive Net Change EHCNegative Net Change
medical medical-devices
Medtronic (MDT) Reports Favorable SPHERE Per-AF Trial Outcome
by Zacks Equity Research
Medtronic's (MDT) Affera Mapping and Ablation System with Sphere-9 Catheter achieves endpoints for safety and efficacy for the treatment of AFib.
MDTNegative Net Change MEDPPositive Net Change HIMSPositive Net Change HITIPositive Net Change
medical medical-devices